LTC Webinar: The relationship between the VC and its portfolio companies

2 July 2020

‘The reason we are so excited about Biotech investments is that the exits we have are oversized in terms of returns. But also with that - we are making an impact on the way we live our lives.’


We were pleased to host a webinar with ARTIS Ventures, pioneering investors in techbio: at the intersection of life sciences and computer sciences. The discussion focused on the relationship between the VC and its portfolio companies. It was great to see first-hand the close relationships between Artis and the CEOs/ Founders within their portfolio.


A special thank you to our fantastic speakers:


It is always encouraging to hear about breakthroughs and success stories in BioTech and healthcare! The future feels more positive as a result of some of the great work discussed.

Please also subscribe to our newsletter to receive information about our future activities.

The value of your investment may go down as well as up and, therefore, your capital is at risk. Investments in venture capital funds and projects are particularly risky and you may lose all your invested capital so you will need to ensure that you are able to afford this loss. Investments should only be made by investors who understand the risks. London Technology Limited (FRN: 821696) is an appointed representative of  Red Sky Capital Solutions LLP (FRN: 530676) which is authorised and regulated by the UK Financial Conduct Authority.

London Technology Club All Rights Reserved 2021. London Technology Club Privacy Policy 2021.